by mouth 1-2 h before operation, alfentanil priming infusion (60 fig kg'
1 min-1 for 10 min) followed by maintenance infusion (4.5 Lorazepam 0.08 mg kg" 1 was administered by mouth to six patients 1-2 h before anaesthesia. All chronic cardiac medications were administered on the morning of surgery and included beta-adrenergic (n = 3) and calcium entry (n = 5) blocking agents. Monitoring was initiated before the induction of anaesthesia and included ECG leads II and V5, systemic arterial pressure and measurement of blood-gas tensions (radial arterial cannula), central venous and pulmonary artery pressures and cardiac output (thermodilution) via a pulmonary artery catheter. Additional monitoring established after the induction of anaesthesia included responses to transcutaneous trainof-four stimulation of the ulnar nerve, urinary output via a bladder catheter, body temperatures (rectal, urinary bladder and nasopharyngeal), end-tidal gas concentrations (mass spectrometry), and breath sounds via an oesophageal stethoscope. Each patient received metocurine 0.05 mg kg" 1 while breathing 100% oxygen. A priming infusion of alfentanil was administered over 10 min followed by a maintenance infusion (table II) . The rates of the priming and maintenance infusions were chosen to provide plasma alfentanil concentrations demonstrated by de Lange and de Bruijn [3] to be adequate for anaesthesia during CABG. Provision was made to use higher infusion rates should the number or intensity of responses prove to be excessive. Measurement of response, or lack thereof, was made at four points: loss of consciousnessdefined as failure of the patient to open the eyes to command, lack of purposeful movement, and failure to respond to tactile stimulation (for example, tapping on the forehead); insertion of a cuffed tracheal tube (ETT) facilitated by suxamethonium-induced neuromuscular blockade; stemotomy (SS); and multiple episodes of electrocoagulation (Bovie) before cardiopulmonary bypass. Responses were classified as major or minor and were divided into two groups: haemodynamic and somatic (table III) . Haemodynamic responses included alterations in heart rate or arterial pressure, or both, while somatic responses included facial grimacing, gross purposeful movement, or eye opening. Suxamethonium was utilized only to facilitate tracheal intubation, opening of the sternum (w = 1, Study 1; n = 10, Study 2), or cardioversion (« = 1, Study 1; n = 3, Study 2). Return of neuromuscular function was verified by return of the train-of-four twitch response before further stimulation. If a somatic or haemodynamic response occurred, alfentanil was administered i.v. as a single injection (table III) . If the response was not controlled, one or two additional bolus doses were administered and the rate of the maintenance infusion was increased to the next highest value. If the maximum infusion rate was achieved and control of the response was still inadequate, provision was made to utilize other drugs (for example nitroglycerin or nitroprusside to control arterial pressure).
Arterial blood for measurement of alfentanil concentrations in plasma was sampled before any stimulus, and at 2-and 5-min intervals after the stimulus. In addition, blood samples were obtained before any bolus dose of alfentanil or increase in the rate of the maintenance infusion and at 2 and 5 min thereafter. Plasma concentrations of alfentanil were determined by radioimmunoassay [2, 4] . 
Study 2: Low dose lorazepam
Lorazepam 0.04 mg kg" 1 was administered as the premedicant by mouth to 13 patients. The patients were studied in exactly the same manner as for Study 1, except that the criteria for defining a haemodynamic response were relaxed slightly (greater increases in systolic arterial pressure were required to justify administration of a bolus of alfentanil or an increase in the infusion rate), the quantity of alfentanil administered as an i.v. bolus was slightly reduced (table III) , and the initial priming and maintenance infusion rates were chosen randomly from one of three different options (table II) .
Differences between the two studies were compared using Student's t test or Chi Square test, and P < 0.05 were taken as statistically significant. All values are expressed as the mean (SEM).
RESULTS
The patients in the two studies were comparable in age, body weight and surface area (table I). A lesser proportion of patients in Study 1 were taking beta-adrenergic blocking agents and a larger proportion were taking calcium entry blocking drugs than in Study 2. The duration of alfentanil infusion was not statistically different between the two studies (96 (8) min, Study 1; 101 (7) min, Study 2; P = 0.7).
Study 1
The six patients receiving lorazepam 0.08 mg kg" 1 as premedicant had a satisfactory intraoperative course with a mean maintenance alfentanil infusion rate of 5.9 (0.9) ug kg"
1 min x and an average plasma alfentanil concentration of 1178 (54) ng ml" 1 . Three patients demonstrated no response to any stimulus at a mean plasma alfentanil concentration of 1090 (80) ng ml" 1 and required no alfentanil supplement. Among the other three patients, somatic responses were observed 17 times (24.6%) out of 69 determinations of responsiveness. These responses were controlled by bolus doses of alfentanil (major n = 14; minor n = 0) and by increasing the maintenance infusion rate incrementally to 8.7 ug kg" 1 min" 1 (n = 2). Sixteen of the 17 somatic responses occurred in two patients and some difficulty was experienced in controlling the responses until the highest infusion rate was used to produce plasma alfentanil concentrations of 1480 (137) and 1443 (233) ng ml" 1 in these two patients. No haemodynamic responses were observed in either of these two patients. One other patient required nitroglycerin after sternotomy to treat an increase in pulmonary artery occlusion pressure (from 13 to 20 mm Hg) secondary to an increase in mean systemic arterial pressure (from 72 to 90 mm Hg) which was unresponsive to bolus doses of alfentanil (total dose of 100 ug kg" 1 administered over 10 min) that resulted in an alfentanil plasma concentration of only 1039 ng ml" 1 .
Study 2
All 13 patients receiving lorazepam 0.04 mg kg" 1 as premedication demonstrated a response (somatic or haemodynamic, or both) to one or more of the stimuli regardless of which maintenance infusion rate was used initially (5.4, 6.6, or 7.8 ug kg^min" 1 ). Out of a total of 100 measurement points for the 13 patients, somatic responses were recorded 34 times in nine patients (70% of the patients in the group). These responses were controlled by alfentanil bolus doses (11 major and 15 minor boluses) and by increasing the infusion rate (n = 2). In seven of the nine patients only somatic responses (n = 26) occurred and the mean plasma concentration of alfentanil at the times of responding was 2133 (110) ng ml"" 1 (P< 0.0005 v. 1190(lll)ngml-1 for Study 1). The difference between the number of patients exhibiting somatic responses between the two studies was statistically significant (P < 0.005).
Haemodynamic responses occurred in seven (54%) patients in Study 2. In four of these patients (two following insertion of aortic pursestring suture and two following aortic cannulation), haemodynamic control could not be achieved with alfentanil alone. This necessitated the administration of sodium nitroprusside for control of mean aortic pressure («= 4) and nitroglycerin (n = 1) for ischaemic changes on the electrocardiogram. In one patient, the administration of alfentanil sufficient to produce alfentanil plasma concentrations as high as 4600 ng ml" 1 did not control the hypertensive response. The difference between the number of patients requiring treatment for adverse haemodynamic responses in Study 2 v. Study 1 was statistically significant (P < 0.05). The mean maintenance alfentanil infusion rate for group 2 as a whole was 6.8 (0.3) ug kg" 1 min" 1 which, in combination with the bolus doses of alfentanil, produced a mean plasma alfentanil concentration of 2181 (62) ng ml" 1 . Except for the plasma concentrations measured at the time of tracheal intubation, there were statistically significant differences between the average plasma alfentanil concentrations that prevented responses to the stimuli, both discrete (ETT and SS) and repetitive (Bovie) in the two groups (table IV) .
Rigidity on induction of anaesthesia occurred in 14 of the 19 patients and was promptly relieved by suxamethonium. Suxamethonium was again required in 12 patients to facilitate opening of the sternum.
No patient had recall of intraoperative events when interviewed 1-3 days after surgery.
Bradycardia did not occur in either study and no patient in either study required alfentanil for increased heart rate in relation to noxious stimulation.
The mean systemic arterial pressures (mm Hg) did not differ between the two studies before the induction of anaesthesia (90 (3) Study 1; 100 (5) Study 2; P = 0.12), nor was there any difference in the mean arterial pressures measured at loss of consciousness (77 (3) Study 1 v. 73 (5) Study 2; P = 0.54). Decreases in the mean systemic pressure with loss of consciousness (90 (3) to 77 (3) mm Hg Study 1, P = 0.01; 100(5) to 73 (5) mm Hg Study 2; P = 0.005) were statistically significant in both groups. Administration of phenylephrine 25-100 ug i.v. to support the mean systemic pressure was required in four of six patients in Study 1 (67%) and in three of 13 patients in Study 2 (23%) (P < 0.001).
DISCUSSION
The anaesthetic conditions observed in our two studies were quite different. Study 1 was modelled on that of de Lange and de Bruijn, who used the same large dose of lorazepam (0.08 mg kg" 1 ) as a premedicant [3] . A priming dose followed by a constant infusion of alfentanil produced satisfactory anaesthetic and haemodynamic conditions in five of the six patients in Study 1. In two of these five patients, supplementary doses of alfentanil were required to prevent movement to noxious stimuli. The sixth patient had an increase in systemic arterial pressure associated with signs of myocardial ischaemia (increased pulmonary artery occlusion pressures, ECG changes) which were reversed with nitroglycerin. It should be noted that, despite additional doses of alfentanil, the plasma concentrations obtained in this sixth patient remained below those associated with satisfactory conditions in the other five patients in Study 1 (see below).
After the smaller premedicant dose of lorazepam (Study 2), the higher incidence of somatic and haemodynamic responses to noxious stimulation necessitated very frequent supplementation of the alfentanil infusion by single i.v. doses of the opioid. Despite the generous administration of alfentanil, control of haemodynamic responses was not achieved with alfentanil alone in four of the 13 patients.
In regard to the alfentanil plasma concentration v. response relationship for noxious stimulation during coronary artery operations, we found that the concentrations associated with satisfactory conditions after the higher premedicant dose of lorazepam (Study 1) were similar to those reported by de Lange and de Bruijn [3] . Robbins and co-workers also found that plasma concentrations of approximately 1000 ng ml" 1 were associated with satisfactory haemodynamic conditions in patients undergoing cardiac operations after premedication with diazepam, morphine and hyoscine [5] . Intermittent supplementation of the constant infusion of alfentanil was occasionally required in the patients receiving the higher dose of lorazepam to control haemodynamic responses to noxious stimulation in our study as well as that by de Lange and de Bruijn [3] . In contrast to previously published investigations we minimized the use of neuromuscular blocking drugs in order to allow observation of somatic responses to noxious stimulation. While somatic responses occurred in patients in both studies, control of these responses was much easier in those patients receiving the higher dose of lorazepam.
Despite significantly higher plasma concentrations of alfentanil in the patients in Study 2 (2000-3000 ng ml" 1 v. 1000-1500 ng ml" 1 for Study 1), the somatic and haemodynamic responses in four of the patients in Study 2 were not controlled, despite alfentanil concentrations as high as 1600-4600 ng ml" 1 . Also, the control of somatic responses in patients in Study 2 required alfentanil concentrations two times greater than those found to be necessary in patients in Study 1. Haemodynamic responses could be controlled by vasodilators and somatic responses could be controlled by the use of neuromuscular blockers, but perhaps at the risk of allowing recall of intraoperative events [6, 7] .
Thus it appears that the role of preanaesthetic medication in the prevention of undesirable somatic and haemodynamic responses is a significant one in the case of alfentanil and probably for other opioids used in anaesthesia.
Investigations in animals have clearly demonstrated that opioids alone are not anaesthetics [8] [9] [10] [11] [12] . The maximum reduction of enflurane MAC (a measure of anaesthetic efficacy) achievable with pure opioid agonists was approximately 70% in dogs. The plasma concentrations of fentanyl-type opioids just sufficient to produce the maximum reduction of enflurane MAC in dogs are remarkably similar to the plasma concentrations of these drugs associated with satisfactory anaesthetic and haemodynamic conditions in humans receiving nitrous oxide or substantial doses of premedicant drugs [2, 8, 9, 11, [13] [14] [15] .
No study to date has demonstrated the feasibility of maintaining surgical anaesthesia with an opioid alone (in the absence of other central nervous system depressants and neuromuscular blocking drugs). It may be unreasonable to expect opioids acting at discrete receptors in the central nervous system to be complete anaesthetics.
We conclude that alfentanil alone is not sufficient to provide satisfactory suppression of haemodynamic and somatic responses to noxious stimulation in patients undergoing coronary artery bypass operations, and that preanaesthetic medication plays a substantial role in the production of satisfactory conditions when an opioid such as alfentanil is used.
